| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS | Park K.; Vansteenkiste J.; Lee K.H.; Pentheroudakis G.; Zhou C.; Prabhash K.; Seto T.; Voon P.J.; Tan D.S.W.; CHIH-HSIN YANG ; Wang J.; Babu K.G.; Nakayama Y.; Alip A.; Chua K.L.M.; CHIA-HSIEN CHENG ; Senan S.; Ahn Y.C.; Kim T.-Y.; Ahn H.K.; Peters S.; Yoshino T.; Douillard J.-Y. | Annals of Oncology | 50 | 49 | |
| 2022 | Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial | YEN-SHEN LU ; Im S.-A.; Colleoni M.; Franke F.; Bardia A.; Cardoso F.; Harbeck N.; Hurvitz S.; Chow L.; Sohn J.; Lee K.S.; Campos-Gomez S.; Vazquez R.V.; Jung K.H.; Babu K.G.; Wheatley-Price P.; De Laurentiis M.; Im Y.-H.; Kuemmel S.; El-Saghir N.; O'Regan R.; Gasch C.; Solovieff N.; Wang C.; Wang Y.; Chakravartty A.; Ji Y.; Tripathy D. | Clinical Cancer Research | 27 | 21 |
